Glipizide and Metformin FDC - Effective, Safe and Cost-Effective in T2D: Latest Indian Real-World Study
- byDoctor News Daily Team
- 09 September, 2025
- 0 Comments
- 0 Mins

A real-world Indian study found that glipizide, alone or with metformin, improves glycemic control in patients with declining renal function without impacting weight or beta-cell function. This study has been conducted by leading researchers and endocrinologist V. Mohan, TA Pramod Kumar, Rajendra Pradeepa, Saravanan Jebarani, Sadasivam Ganesan, Abhijit Pednekar, Routray Philips, Suraparaju Pavan Kumar, Ranjit Unnikrishnan, Ranjit Mohan Anjana and published in the journalDrugs - Real World Outcomes. This retrospective study, conducted at a tertiary diabetes center in India covering an extensive 30-year span of Diabetes Electronic Medical Records (DEMR), including 11,949 adultswith type 2 diabetes treated with glipizide or glipizide with metformin. Patients had at least one follow-up within a year. The primary outcome was change in HbA1c, while secondary outcomes included fasting and postprandial glucose, body mass index (BMI), and estimated glomerular filtration rate (eGFR). The results revealed findings which include: These findings suggest that glipizide, one of the oldest antidiabetic drugs, and its use in combination with metformin remain safe and effective, both as monotherapy and in combination, particularly in specific situations within resource-constrained settings like India. Furthermore, glipizide with metformin, costing just ₹121 monthly, is among the most affordable antidiabetic treatment options in India, improving access for deserving lower-income groups living with T2D. 1) PramodKumar TA, Pradeepa R, Jebarani S, Ganesan S, Pednekar A, Philips R, Kumar SP, Unnikrishnan R, Anjana RM, Mohan V. Effectiveness of Glipizide and Glipizide Plus Metformin Formulation among Asian Indians with Type 2 Diabetes: a Real-World, Retrospective Electronic Medical Record Analysis. Drugs Real World Outcomes. 2025 Sep;12(3):457-466. doi: 10.1007/s40801-025-00502-0. Epub 2025 Jul 10. PMID: 40637807; PMCID: PMC12381306.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Recent News
AI Reads Mammograms to Predict Heart Disease Risk...
- 18 September, 2025
Study Reveals Mediterranean Diet Reduces Gum Infla...
- 18 September, 2025
Lower Irisin Levels Linked to Diabetic Nephropathy...
- 18 September, 2025
Androgenic anabolic steroids exposure associated w...
- 18 September, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!